Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rank in Stocks
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Share Price
$3.89
Market Cap
$3.30B
Change (1 day)
-3.14%
Change (1 year)
43.11%
Country
CN
Trade Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Category
Healthcare
P/E ratio for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
P/E ratio as of October 2026 TTM: 109.22
According to Guangdong Zhongsheng Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 109.22. At the end of 2024 the company had a P/E ratio of -33.75.
P/E ratio history for Guangdong Zhongsheng Pharmaceutical Co., Ltd. from 2006 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 109.22 | 89.88% |
| 2025 | 57.52 | -270.42% |
| 2024 | -33.75 | -167.21% |
| 2023 | 50.22 | -25.57% |
| 2022 | 67.48 | 94.31% |
| 2021 | 34.73 | -267.34% |
| 2020 | -20.75 | -164.63% |
| 2019 | 32.11 | 123.97% |
| 2018 | 14.34 | -35.67% |
| 2017 | 22.29 | -0.74% |
| 2016 | 22.45 | -30.47% |
| 2015 | 32.29 | 4.28% |
| 2014 | 30.97 | -18.26% |
| 2013 | 37.88 | 22.52% |
| 2012 | 30.92 | 17.63% |
| 2011 | 26.29 | -35.95% |
| 2010 | 41.04 | -2.53% |
| 2009 | 42.11 | -42.10% |
| 2008 | 72.73 | -43.55% |
| 2007 | 128.83 | -24.57% |
| 2006 | 170.79 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 23.30 | -78.67% |
DE
|
|
| 26.92 | -75.35% |
DE
|
|
| 55.58 | -49.11% |
JP
|
|
| 61.13 | -44.03% |
CH
|
|
| 34.87 | -68.07% |
IN
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.